Romosozumab-alendronate lowers fracture risk in women with osteoporosis | ASBMR

A 48% lower risk of new vertebral fracture was observed in romosozumab-to-alendronate group.
A 48% lower risk of new vertebral fracture was observed in romosozumab-to-alendronate group.